Showing results (651-660 of 889) with videos related to

Sort By:
Pageof 89
Metabolism: Clinical and Experimental|February 7, 2026
Enduring improvements in hepatic insulin sensitivity predict sustained remission of prediabetes during a 3-year lifestyle intervention: results from the PREVIEW multinational diabetes prevention trialRuixin Zhu, Jie Guo, Maija Huttunen-Lenz, et al.
Nutrients|May 6, 2020
Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver DiseaseNuria Perez-Diaz-Del-Campo, Itziar Abete, Irene Cantero, et al.
Panminerva Medica|April 19, 2022
A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markersNuria Perez-Diaz-Del-Campo, Jose I Riezu-Boj, Bertha A Marin-Alejandre, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 16, 2019
Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome featuresVanessa Bullón-Vela, Itziar Abete, Josep A Tur, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 28, 2013
Impact of weight loss and maintenance with ad libitum diets varying in protein and glycemic index content on metabolic syndromeAngeliki Papadaki, Manolis Linardakis, Maria Plada, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 9, 2025
Novel RSAD2 isoforms lacking antiviral activities are originated from alternative splicing and expressed in patients with rheumatic diseasesMariela Gómez-Moreno, Rosalinda Najera-Lerma, Jaquelin Partida-Lozano, et al.
Nutrients|October 27, 2019
The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled TrialBertha Araceli Marin-Alejandre, Itziar Abete, Irene Cantero, et al.
European Journal of Nutrition|January 21, 2021
Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) StudyNuria Perez-Diaz-Del-Campo, Bertha Araceli Marin-Alejandre, Irene Cantero, et al.
Pediatric Diabetes|May 28, 2011
Changes in cardiometabolic risk factors, appetite-controlling hormones and cytokines after a treatment program in overweight adolescents: preliminary findings from the EVASYON studyJavier Romeo, David Martinez-Gomez, L Esperanza Diaz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 10, 2020
MOG-IgG1 and co-existence of neuronal autoantibodiesAmy Kunchok, Eoin P Flanagan, Karl N Krecke, et al.
Pageof 89